返回 Agenda
Digital Technology to Advance Drug Supervision and Patient Access
Session Chair(s)
RenHua Rochelle KOU
AstraZeneca, China
This objective of the session is to introduce the overall digital technology impacts in healthcare system and patient access, and its acceleration of new drug R&D includes spurring upstream drug development and improving the effectiveness of downstream product life cycle management. This forum will bring together key thought leaders from Regulators, healthcare professional, pharmaceutical industry and media giants together to discuss the adoption of digital technology advances drug development, supervision, patient access tec. The key topics will be including US FDA’s Technology Modernization Action Plan; cloud-based regulatory information management system and its best practice sharing; the dynamic evolution of innovative digital healthcare solution and its opportunities and challenges. The panel discussion will provide opportunity for the audience to interact with the speakers and invited additional digital experts to share the broad viewpoints of digital technology used in healthcare management, i.e, digital tools advances operation efficiency amid Covid-19 pandemic